At the box office, bad boy pharma on top

In another blow to pharma's tattered image among the public, Rise of the Planet of the Apes makes drug developer Will and Big Pharma the agents of unprecedented disaster. "Will is a brilliant, but cold pharmaceutical scientist who, instead of finding a cure for Alzheimer's disease, starts the cataclysmic extinction of man." Alas, it topped the weekend box office receipts in North America at $54 million, more than double the take of second-place The Smurfs. Review | Box Office Rundown

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.